Helper and cytotoxic T‐cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors
- 27 May 2016
- journal article
- Published by Wiley in Oral Diseases
- Vol. 22 (6) , 566-572
Abstract
Objective: The objective of this study was to explore the prevalence of T helper type 1 (Th1; CD4+IFN‐γ +) and Th2 (CD4+IL‐4+) cells, as well as cytotoxic T cell type 1 (Tc1; CD8+IFN‐γ+) and Tc2 cells (CD8+IL‐4+) in peripheral blood of the patients with salivary gland tumors (SGTs).Subjects and Methods: Thirty new patients with SGTs and 15 healthy controls were recruited. After intracellular cytokine staining, data acquisition and analysis were performed by flow cytometry.Results: The mean percentages of Th1 and Tc1 cells, as well as the ratios of Th1/Th2 and Tc1/Tc2, were observed to be significantly lower in patients with malignant SGTs in comparison with controls. Furthermore, the geometric mean fluorescent intensity (geometric MFI, representing the cytokine expression intensity) for IL‐4 production by Th2 and Tc2 lymphocytes was significantly higher in patients with malignant tumors than controls. Positive correlations were observed between the mean percentage of Tc2 cells with Th2 cells, and with the tumor size in patients with benign and malignant tumors, respectively.Conclusion: The findings suggest that the imbalance of Th1/Th2 and Tc1/Tc2 ratios, as well as the increase in the expression of IL‐4 by Th2 and Tc2 lymphocytes, may contribute to the pathogenesis of SGTs, especially in malignant cases.Keywords
Funding Information
- Shiraz University of Medical Sciences
This publication has 22 references indexed in Scilit:
- Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodesImmunology Letters, 2014
- Effector memory T‐cell frequencies in relation to tumour stage, location and HPV status in HNSCC patientsOral Diseases, 2012
- Lymphocytes in cancer development: Polarization towards pro-tumor immunityCytokine & Growth Factor Reviews, 2010
- IL-4 Suppresses Very Late Antigen-4 Expression Which is Required for Therapeutic Th1 T-cell Trafficking Into TumorsJournal of Immunotherapy, 2009
- Hypoxia skews dendritic cells to a T helper type 2‐stimulating phenotype and promotes tumour cell migration by dendritic cell‐derived osteopontinImmunology, 2009
- IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefitEuropean Journal of Immunology, 2008
- Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neckCancer Immunology, Immunotherapy, 2005
- Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancerClinical Immunology, 2004
- Salivary gland tumoursOral Diseases, 2002
- The Tumor Enhancement Phenomenon: Reinterpretation From a Th1/Th2 PerspectiveJNCI: Journal of the National Cancer Institute, 1996